IL-6 can stimulate colon cancer and activate the NF-κB pathway, as well as regulate intestinal tight junction, induce intestinal immunity, and incite intestinal inflammation (Cuellar-Nunez et al., 2021). Here, NFKB1 is linked to colonic neoplasm.